Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status

Concurrent chemoradiotherapy (cCRT) is the standard treatment for patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, the efficacy and safety of this treatment has not been compared between patients who possess epidermal growth factor receptor (EGFR) mutations and patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Ishihara, Mikiko, Igawa, Satoshi, Sasaki, Jiichiro, Otani, Sakiko, Fukui, Tomoya, Ryuge, Shinichiro, Katono, Ken, Hiyoshi, Yasuhiro, Kasajima, Masashi, Mitsufuji, Hisashi, Kubota, Masaru, Yokoba, Masanori, Katagiri, Masato, Sekiguchi, Akane, Soda, Itaru, Ishiyama, Hiromichi, Hayakawa, Kazushige, Masuda, Noriyuki
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494758/
https://ncbi.nlm.nih.gov/pubmed/28693247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6231
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados